Adverse events98

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

81 to 98 of 98

Type	Event	Organ system	Group	Affected	At risk
serious	Nephrolithiasis	Renal and urinary disorders	Placebo	1	163
serious	Nephrolithiasis	Renal and urinary disorders	Relamorelin 10 μg	0	163
serious	Acute respiratory failure	Respiratory, thoracic and mediastinal disorders	Placebo	2	163
serious	Acute respiratory failure	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Asthma	Respiratory, thoracic and mediastinal disorders	Placebo	1	163
serious	Asthma	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Hypercapnia	Respiratory, thoracic and mediastinal disorders	Placebo	1	163
serious	Hypercapnia	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Pulmonary embolism	Respiratory, thoracic and mediastinal disorders	Placebo	1	163
serious	Pulmonary embolism	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Placebo	1	163
serious	Pulmonary oedema	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Respiratory failure	Respiratory, thoracic and mediastinal disorders	Placebo	1	163
serious	Respiratory failure	Respiratory, thoracic and mediastinal disorders	Relamorelin 10 μg	0	163
serious	Hypertension	Vascular disorders	Placebo	1	163
serious	Hypertension	Vascular disorders	Relamorelin 10 μg	1	163
serious	Hypovolaemic shock	Vascular disorders	Placebo	1	163
serious	Hypovolaemic shock	Vascular disorders	Relamorelin 10 μg	0	163

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03285308/events?page=5